Globe Life Inc. $GL Shares Bought by Cwm LLC

Cwm LLC lifted its holdings in Globe Life Inc. (NYSE:GL) by 72.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,225 shares of the company’s stock after purchasing an additional 16,530 shares during the period. Cwm LLC’s holdings in Globe Life were worth $4,875,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Nuveen LLC purchased a new position in shares of Globe Life in the first quarter worth approximately $131,608,000. Swedbank AB increased its position in shares of Globe Life by 77.0% in the first quarter. Swedbank AB now owns 832,000 shares of the company’s stock worth $109,591,000 after acquiring an additional 362,000 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its position in shares of Globe Life by 35.9% in the first quarter. Jacobs Levy Equity Management Inc. now owns 1,025,984 shares of the company’s stock worth $135,143,000 after acquiring an additional 271,253 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of Globe Life by 1,270.8% in the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 233,030 shares of the company’s stock worth $28,963,000 after acquiring an additional 216,030 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in shares of Globe Life by 28.8% in the first quarter. AQR Capital Management LLC now owns 706,142 shares of the company’s stock worth $91,996,000 after acquiring an additional 157,773 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Stock Performance

GL stock opened at $138.14 on Thursday. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $11.19 billion, a price-to-earnings ratio of 11.04 and a beta of 0.55. Globe Life Inc. has a 12 month low of $100.27 and a 12 month high of $147.83. The firm has a 50 day moving average of $140.11 and a two-hundred day moving average of $128.95.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, topping the consensus estimate of $3.25 by $0.02. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.50 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.97 earnings per share. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. As a group, equities analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life’s payout ratio is currently 8.63%.

Insider Buying and Selling at Globe Life

In other news, EVP Michael Clay Majors sold 10,000 shares of the business’s stock in a transaction on Friday, August 1st. The shares were sold at an average price of $137.41, for a total value of $1,374,100.00. Following the completion of the sale, the executive vice president directly owned 47,066 shares in the company, valued at approximately $6,467,339.06. The trade was a 17.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the completion of the sale, the chief executive officer owned 32,747 shares of the company’s stock, valued at $4,629,770.86. The trade was a 27.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 84,722 shares of company stock valued at $11,733,793. 1.51% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on GL. Keefe, Bruyette & Woods lifted their target price on shares of Globe Life from $145.00 to $155.00 and gave the stock an “outperform” rating in a research report on Monday, July 28th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Globe Life in a research report on Wednesday, October 8th. Morgan Stanley set a $179.00 price objective on shares of Globe Life and gave the company an “overweight” rating in a research report on Tuesday, October 7th. BMO Capital Markets reaffirmed a “market perform” rating and set a $149.00 price objective (up from $114.00) on shares of Globe Life in a research report on Wednesday, July 30th. Finally, Wells Fargo & Company boosted their price objective on shares of Globe Life from $150.00 to $172.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $152.11.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.